Trial Profile
A Phase 1, Open-label, One-sequence Crossover Study to Evaluate the Effect of Multiple Doses of FG 4592 on the Pharmacokinetics of Warfarin in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Mar 2016
Price :
$35
*
At a glance
- Drugs Roxadustat (Primary) ; Warfarin (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 03 Mar 2016 Results published in the Clinical Therapeutics
- 07 Oct 2014 New trial record